Lastly, that circulating levels of MPZ mRNA were reduced in persons with T2D and DPN, discriminated DPN + from DPN- with high accuracy, and correlated with neuropathy scores as well as small- and large nerve fiber affection. This evidence concerns the gene MPZ and type 2 diabetes mellitus.